Long-term expression of a foreign gene from a unique position in the latent herpes simplex virus genome

Human Gene Therapy

Volumn 7, Issue 12, 1996, Pages 1447-1454

  Carpenter, D E ^a   Stevens, J G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE CONSTRUCT; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS; HISTOCHEMISTRY; LATENT VIRUS INFECTION; LONG TERMINAL REPEAT; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL GANGLION; VIRAL GENETICS;

EID: 0029830965     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.12-1447     Document Type: Article

References (31)

1. BREAKEFIELD, X.O., and DELUCA, N.A. (1991). Herpes simplex virus for gene delivery to neurons. New Biol. 3, 203-218.
2. BROWN, S.M., D.A. RITCHIE, and J.H. SUBAK-SHARPE. (1973). Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangements into complementation groups and recombination analysis leading to a linkage map. J. Gen. Virol. 18, 329-346.
3. CARPENTER, D.E., and STEVENS, J.G. (1994). Development of HSV-1 viral vectors for stable gene transfer into neurons. Proceedings of the 19th International Herpesvirus Workshop. University of British Columbia, Vancouver, Canada.
4. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single step method for the RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Bioch. 162, 156-159.
5. COOK, M.L., and STEVENS, J.G. (1973). Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection. Infect. Immun. 7, 272-288.
6. DOBSON, A.T., SEDERATI, F., DEVI-RAO, G., FLANAGAN, W.M., FARRELL, M.J., STEVENS, J.G., WAGNER, E.K., and FELDMAN, L.T. (1989). Identification of the latency-associated transcript promoter by expression of rabbit beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus. J. Virol. 63, 3844-3851.
7. DOBSON, T., MARGOLIS, T.P., SEDARATI, F., STEVENS, J.G., and FELDMAN, L.T. (1990). A latent, nonpathogenic HSV-1-derived vector stably expresses b-galactosidase in mouse neurons. Neuron 5, 353-360.
8. EFSTATHIOU, S., and MINSON, A.C. (1995). Herpes virus-based vectors. Br. Med. Bull. 51, 45-55.
9. FREESE, A., GELLER, A.I., and NEVE, R. (1990). HSV-1 vector mediated neuronal gene delivery. Strategies for molecular neuroscience and neurology. Biochem. Pharmacol. 40, 2189-2199.
10. GLORIOSO, J.C., GOINS, W.F., MEANEY, C.A., FINK, D.J., and DELUCA, N.A. (1994). Gene transfer to brain using herpes simplex virus vectors. Ann. Neurol. 35(Suppl), S28-S34.
11. GOINS, W.F., STERNBERG, L.R., CROEN, K.D., KRAUSE, P.R., HENDRICKS, R.L., FINK, D.J., STRAUS, S.E., LEVINE, M., and GLORIOSO, J.C. (1994). A novel latency-active promoter is contained within the herpes simplex virus type 1 Ul flanking repeats. J. Virol. 68, 2239-2252.
12. GOLDSTEIN, D.J., and WELLER, S.K. (1988a). Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant. J. Virol. 62, 196-205.
13. GOLDSTEIN, D.J., and WELLER, S.K. (1988b). An ICP6:lacZ insertional mutagen is used to demonstrate that the UL52 gene of herpes simplex virus type 1 is required for virus growth and DNA synthesis. J. Virol. 62, 2970-2977.
14. GOODART, S.A., GUZOWSKI, J.F., RICE, M.K., and WAGNER, E.K. (1992). Effect of genomic location on expression of the β-galactosidase mRNA controlled by the herpes simplex virus type UL38 promoter. J. Virol. 66, 2973-2981.
15. LECONTE, L., SEMONIN, O., ZVARA, A., BOISSEAU, S., POUJEOL, C., JULIEN, J.P., and SIMONNEAU, M. (1994-95). Both upstream and intragenic sequences of the human neurofilament light gene direct expression of lacZ in neurons of transgenic mouse embryos. J. Mol. Neurosci. 5, 273-295.
16. LEIB, D.A., and OLIVO, P.D. (1993). Gene delivery to neurons: Is herpes simplex virus the right tool for the job? BioEssays 15, 547-554.
17. LIGAS, M.W., and JOHNSON, D.C. (1988). A herpes simplex virus mutant in which glycoprotein D sequences are replaced by b-galactosidase sequences binds to but is unable to penetrate into cells. J. Virol. 62, 1486-1494.
18. LOKENSGARD, J.R., BLOOM, D.C., DOBSON, A.T., and FELDMAN, L.T. (1994). Long-term promoter activity during herpes simplex virus latency. J. Virol. 68, 7148-7158.
19. MARGOLIS, T.P., BLOOM, D.C., DOBSON, A.T., FELDMAN, L.T., and STEVENS, J.G. (1993). Decreased reporter gene expression during latent infection with HSV LAT promoter constructs. Virology 197, 585-592.
20. MEHTA, A., MAGGIONCALDA, J., BAGASRA, O., THIKKAVARAPU, S., SAIKUMARI, P., VALYI-NAGY T., FRASER, N.W., and BLOCK, T.M. (1995). In situ DNA PCR and RNA hybridization detection of herpes simplex virus sequences in trigeminal ganglia of latently infected mice. Virology 206, 633-640.
21. MOCARSKI, E.S., POST, L.E., and ROIZMAN, B. (1980). Molecular engineering of the herpes simplex virus genome: insertion of a second L-S junction into the genome causes additional genome inversions. Cell 22, 243-255.
22. PRICE, J., TURNER, D., and CEPKO, C. (1987). Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 84, 156-160.
23. ROEMER, K., JOHNSON, P.A., and FRIEDMANN, T. (1991). Activity of the simian virus 40 early promoter-enhancer in herpes simplex virus type 1 vectors is dependent on its position, the infected cell type, and presence of the Vmw175. J. Virol. 65, 6900-6912.
24. SMILEY, J.R. (1980). Construction in vitro and rescue of a thymidine kinase-deficient deletion mutation of herpes simplex virus. Nature 285, 333-335.
25. SMILEY, J.R., FONG, B.S., and LEUNG, W.C. (1981). Construction of a double-jointed herpes simplex viral DNA molecule: Inverted repeats are required for segment inversions, and direct repeats promote deletions. Virology 113, 345-362.
26. SPAETE, R.R., and FRENKEL, N. (1982). The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vector. Cell 30, 295-304.
27. STEVENS, J.G., WAGNER, E.K., DEVI-RAO, G.B., COOK, M.L., and FELDMAN, L.T. (1987). RNA complimentary to a herpesvirus alpha gene mRNA is predominent in latently infected neurones. Science 235, 1056-1059.
28. STEVENS, J.G. (1989). Human herpesviruses: a consideration of the latent state. Microbiol. Rev. 53, 318-332.
29. THOMPSON, R.L., COOK, M.L., DEVI-RAO, G.B., WAGNER, E.K., and STEVENS, J.G. (1986). Functional and molecular analysis of the avirulent wild-type herpes simplex virus type 1 strain KOS. J. Virol. 58, 203-211.
30. WILDY, P. (1955). Recombination with herpes simplex virus. J. Gen. Microbiol. 13, 346-360.
31. YUHASZ, S., DISSETTE, V.B., COOK, M.L., and STEVENS, J.G. (1994). Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice. Virology 202, 272-280.